Literature DB >> 15655452

Mucosa-associated lymphoid tissue lymphoma with intraocular involvement.

David Sarraf1, Atul Jain, Sander Dubovy, Allan Kreiger, Donald Fong, John Paschal.   

Abstract

PURPOSE: To report the clinicopathologic features of a patient with mucosa-associated lymphoid tissue (MALT) lymphoma of the conjunctiva and associated intraocular involvement.
METHODS: This study is a retrospective clinicopathologic correlative case report summarizing the clinical, radiologic, and histopathologic findings of a patient with conjunctival MALT lymphoma and associated intraocular involvement.
RESULTS: Ophthalmic examination and fluorescein angiography demonstrated progressive conjunctival infiltration bilaterally, marked uveal effusions in the left eye, and cellular white infiltrates of the choroid in the right eye. MRI of the orbit revealed a diffusely infiltrating intra- and extraocular lesion extending around the globe and optic nerve in the left eye without evidence of intracranial extension. Conjunctival biopsy showed low-grade tumor cells, consistent with the diagnosis of MALT lymphoma. The patient was successfully treated with external beam radiation with marked clinical improvement.
CONCLUSION: Conjunctival MALT lymphomas, typically indolent and localized tumors, may extend into the orbit and invade local tissues such as the choroid with devastating consequences. A conjunctival biopsy can provide an easy diagnosis of this treatable entity.

Entities:  

Mesh:

Year:  2005        PMID: 15655452     DOI: 10.1097/00006982-200501000-00018

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  18 in total

Review 1.  [Primary uveal lymphoma effectively treated with radiotherapy: a case report and literature review].

Authors:  Ruo-Xin Wu; Tao Yang; Zhu-Ping Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

2.  A case of an enlarged medial rectus muscle.

Authors:  David Rossman; Rene Michel; Francois Codere
Journal:  Int Ophthalmol       Date:  2008-06-19       Impact factor: 2.031

3.  Uveal extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type with concomitant extraocular lesions in a Japanese man.

Authors:  Mizuki Tagami; Takayuki Nagai; Daisuke Sekimukai; Rumiko Hara; Atsushi Azumi
Journal:  Jpn J Ophthalmol       Date:  2011-06-30       Impact factor: 2.447

4.  Choroidal and adnexal extranodal marginal zone B-cell lymphoma: presentation, imaging findings, and therapeutic management in a series of nine cases.

Authors:  P Loriaut; F Charlotte; B Bodaghi; D Decaudin; V Leblond; C Fardeau; L Desjardins; P Lehoang; N Cassoux
Journal:  Eye (Lond)       Date:  2013-04-19       Impact factor: 3.775

5.  High-grade malignant B-cell lymphoma of the retina in a patient with concomitant gastric MALT lymphoma.

Authors:  Zaher H Sbeity; Sarah Coupland; Karin U Loeffler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-06-01       Impact factor: 3.117

Review 6.  Conjunctival Lymphoma.

Authors:  Lindsay A McGrath; David A Ryan; Sunil K Warrier; Sarah E Coupland; William J Glasson
Journal:  Eye (Lond)       Date:  2022-07-26       Impact factor: 4.456

7.  Spectral-domain optical coherence tomography of conjunctival mucosa-associated lymphoid tissue lymphoma with presumed choroidal involvement.

Authors:  Basil K Williams; Irena Tsui; Tara A McCannel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-08       Impact factor: 3.117

Review 8.  The role of infectious agents in the etiology of ocular adnexal neoplasia.

Authors:  Varun Verma; Defen Shen; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 6.048

9.  Ocular surface tumors.

Authors:  Ihab Saad Othman
Journal:  Oman J Ophthalmol       Date:  2009-01

10.  Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution.

Authors:  Francesca Collina; Anna De Chiara; Amalia De Renzo; Gaetano De Rosa; Gerardo Botti; Renato Franco
Journal:  Infect Agent Cancer       Date:  2012-04-02       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.